Christoph Baldow
Dresden, SN, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Modelling of immune response in chronic myeloid leukemia patients suggests potential for treatment reduction prior to cessation.
Journal: Frontiers in oncology
Published: August 26, 2022
Clonal reconstruction from co-occurrence of vector integration sites accurately quantifies expanding clones in vivo.
Journal: Nature communications
Published: February 07, 2022
How to predict relapse in leukemia using time series data: A comparative in silico study.
Journal: PloS one
Published: May 21, 2021
Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML.
Journal: Cancer research
Published: July 18, 2019
Integration of mathematical model predictions into routine workflows to support clinical decision making in haematology.
Journal: BMC medical informatics and decision making
Published: November 08, 2018
Reduced tyrosine kinase inhibitor dose is predicted to be as effective as standard dose in chronic myeloid leukemia: a simulation study based on phase III trial data.
Journal: Haematologica
Published: March 29, 2018
Quantitative prediction of long-term molecular response in TKI-treated CML - Lessons from an imatinib versus dasatinib comparison.
Journal: Scientific reports
Published: August 14, 2017
MAGPIE: Simplifying access and execution of computational models in the life sciences.
Journal: PLoS computational biology
Published: July 20, 2017
Response dynamics of pediatric patients with chronic myeloid leukemia on imatinib therapy.
Journal: Haematologica
Published: November 19, 2016
Drug target prioritization by perturbed gene expression and network information.
Journal: Scientific reports
Published: April 10, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026